Equivalence Study to Compare Two Strengths of Creon in China

Summary

This will be an open-label, randomized, multicenter, cross-over study in 60 subjects with PEI delivering data of 60 subjects for Pancreatin Enteric-Coated Capsules 25000 and of 60 subjects for Pancreatin Enteric-Coated Capsules 10000. The study will be conducted in up to 10 sites in China.

Timeline

Start

2017-08-31

Primary completion

2022-04

Completion

2022-04-30

Drugs

Indications